Improvement in Gastrointestinal Symptoms From Light Chain Amyloidosis After Adalimumab Therapy

Journal article

Open access

Peer reviewed

Abdullah S Al Saleh, M Hasib Sidiqi and Morie A Gertz

Mayo Clinic proceedings, Vol.94(7), pp.1380-1381

07/2019

PMID: 31272581

Abstract

Adalimumab - administration & dosage

Anti-Inflammatory Agents - administration & dosage

Diarrhea - etiology

Gastrointestinal Diseases

Humans

Immunoglobulin Light-chain Amyloidosis - diagnosis

Male

Middle Aged

url

https://doi.org/10.1016/j.mayocp.2019.04.023View

Published (Version of record) Open

1 Record Views

Title: Improvement in Gastrointestinal Symptoms From Light Chain Amyloidosis After Adalimumab Therapy
Creators - without role: Abdullah S Al Saleh - King Saud bin Abdulaziz University for Health Sciences
M Hasib Sidiqi - Mayo Clinic
Morie A Gertz - Mayo Clinic in Florida
Publication Details: Mayo Clinic proceedings, Vol.94(7), pp.1380-1381
Identifiers: 9920986008331
Academic Unit: King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences
Language: English
Resource Type: Journal article